MEETINGS - Conference on Regulation and Marketing for Self Diagnostic and Home Monitoring Products (UK) February 1998:
This article was originally published in Clinica
Regulation and Marketing for Self Diagnostic & Home Monitoring Products is the subject of a conference to be held in London on February 12-13, 1998. Discussion topics include regulatory aspects of the self diagnostics market; the Internet - future sales route for diagnostics; and developments in genetic testing. For more information contact Elaine Rogers at the SMi UK office. Tel: +44 171 252 2222. Fax: +44 171 252 2272.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.